cabosun: upfront use of cabozantinib for mrcc
Published 6 years ago • 291 plays • Length 3:16Download video MP4
Download video MP3
Similar videos
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
2:47
cabozantinib in mrcc
-
1:32
dr. mcgregor on the future of cabozantinib in rcc
-
5:26
mrcc: impact of cabosun and checkmate-214
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
5:56
the rationale for cabozantinib in advanced rcc
-
6:01
cabozantinib in rcc, cost of cancer care, sgr repeal, and more
-
2:12
results of a trial comparing cabozantinib and sunitinib in mrcc
-
2:02
how cabozantinib is being used in practice for patients with rcc
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
1:04
dr. wei on the use of cabozantinib in advanced kidney cancer
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
1:14
dr. jonasch on the cabosun trial in rcc